Diagnostic recombinant B-type natriuretic peptide (BNP) antigens (recombinant B-type natriuretic peptide (BNP) ) protein) for Cardiovascular Disease BNP detection in positive control, ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

BNP) in response to increased mechanical load and wall stretch. BNP protects the heart from adverse consequences of overload by increasing natriuresis and diuresis, relaxing vascular smooth muscle, inhibiting the renin-angiotensin-aldosterone system, and by counteracting cardiac hypertrophy and fibrosis. BNP is synthesized by human cardiac myocytes as a 108-amino acid prohormone (proBNP), which is cleaved to the 32-residue BNP and the 76-residue N-terminal fragment of proBNP (NT-proBNP). Both can be used as sensitive biomarkers of cardiac dysfunction and well-characterized commercial assays have recently become available. In acute coronary syndromes increased concentrations are strong predictors of recurring myocardial infarction, heart failure, and death. In acute dyspnea, high BNP and NT-proBNP point to a cardiac rather than a pulmonary origin of the symptoms. BNP and NT-proBNP help in the assessment of the severity of ventricular dysfunction and heart failure and as a prognostic predictor, regardless of the primary cause of the condition.?

Genemedi produces core diagnostic ingredients for test of Cardiovascular Disease and related syndrome. GeneMedi offers paired diagnostics grade B-type natriuretic peptide (BNP) antibodies (monoclonal antibody, mab) and B-type natriuretic peptide (BNP) antigens for Cardiovascular Disease rapid test kit of B-type natriuretic peptide (BNP) testing in positive control, ELISA test,Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

All the antibodies and antigens for Cardiovascular Disease test are suitable for in functional ELISA, and other immunoassays in dignostics. The antibodies can act as a capture antibody and detection antibody. The antigens can be used for antibodies rapid test of Cardiovascular Disease.

Order information

Catalog No.	Size	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-BNP-Ag	Size:1mg	3090
GMP-BNP-Ag	Size:10mg	21890
GMP-BNP-Ag	Size:100mg	148000
GMP-BNP-Ag	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Cat No.	GMP-BNP-Ag
Product Name	Recombinant B-type natriuretic peptide (BNP, His Tag)
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	B-type natriuretic peptide (BNP) Antibody Binding, Immunogen in Sandwich ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Tag	His
Products description	Recombinant B-type natriuretic peptide (BNP, His Tag) is produced by E.coli expression system with a 6His tag.
Specics	NA
Purity	Purity: ≥95% (SDS-PAGE)
Application	positive control,ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.